🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with coronary artery calcium score changes on glp-1? Page 3

Has anyone dealt with coronary artery calcium score changes on glp-1?

KarenAZ_mom Thu, Apr 4, 2024 at 11:16 PM 35 replies 2,233 viewsPage 3 of 7
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Apr 5, 2024 at 8:13 AM#11
anna.melb_AU said:
Lp(a) and cardiovascular risk: a nuance that matters.

Mendelian randomization evidence supporting GLP-1 pathway modulation for cardiovascular risk: genetic variants in the GLP1R gene region associated with lower BMI also show associations with reduced cardiovascular risk, confirming a causal pathway[1].

This "natural experiment" (people born with genetically higher GLP-1 signaling being leaner and healthier) provides orthogonal evidence supporting the pharmacological approach. When genetic epidemiology, clinical trials, and mechanistic studies all converge, confidence in the therapeutic approach is high.

References:
[1] Zheng SL, et al. Lancet Diabetes Endocrinol. 2023;11(12):869-879.
35 8denise_HTX, raj_cambridge, ingrid_STO and 32 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Apr 5, 2024 at 11:37 AM#12
fiona_glasgow said:
mike_nyc said: ...we're creating a generation dependent on cardiovascular risk...

This is exactly what I could not find anywhere else.

36 9ricardo_MIA, BrianDallas92, labquiet_amy and 33 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Apr 5, 2024 at 3:01 PM#13
anna.melb_AU said:
Lp(a) and cardiovascular risk: a nuance that matters.

Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling, reduces NLRP3 inflammasome activation, and decreases monocyte/macrophage adhesion to endothelium[1].

Clinical correlates: hsCRP reduction of 30-60% (consistently seen across trials), reduced carotid intima-media thickness, and decreased coronary plaque inflammation on PET imaging.

These anti-inflammatory effects likely contribute to the cardiovascular benefit seen in SELECT — and may explain benefits beyond what weight loss alone would predict.

References:
[1] Hogan AE, et al. Diabetologia. 2014;57(4):781-784.
37 10NicoleRaleigh, james_edin, FranDenver and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Apr 5, 2024 at 6:24 PM#14
KarenAZ_mom said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Senior perspective on cardiovascular risk: I'm 65 years old and started this journey skeptically. My endocrinologist recommended it after years of failed interventions.

11 months later: down 53 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

Last edited: Apr 5, 2024 at 7:24 PM
38 11DebRD_ATL, KristenIndy, MarkLI_maint and 35 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 5, 2024 at 9:47 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Carry on.

Last edited: Apr 6, 2024 at 1:47 AM
39 12PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register